Загрузка...
695. Activity of Imipenem–Relebactam and Ceftolozane–Tazobactam Against a Contemporary Collection of Gram-Negative Bacteria from New York City
BACKGROUND: Carbapenem-resistant Gram-negative bacteria are important nosocomial pathogens, and therapeutic options are often limited. METHODS: Clinical isolates were gathered during a surveillance study in 2017 involving 7 hospitals in Brooklyn, NY. Isolates underwent susceptibility testing using t...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811245/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.763 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|